Content
All Posts > Content under Pharma/Biotech
Chembio's Stock Craters After Coronavirus Antibody Test Emergency Use Is Revoked
Article By:
Benzinga
Read
Wednesday, June 17, 2020 10:37 AM EDT
Shares of Chembio Diagnostics Inc., which rallied nicely following the launch of its rapid DPP COVID-19 serological point-of-care test for the detection of IgM and IgG antibodies in late March, are pulling back sharply Wednesday.
In this article: CEMI
Fire And Flower Is Leading The Pack Of Canadian Cannabis Retailers
Article By:
Technical420
Read
Wednesday, June 17, 2020 8:40 AM EDT
2020 has been a challenging year for the Canadian cannabis retail market as the industry has been impacted by the COVID-19 outbreak.
In this article: FFLWF
Markets Continue To Bounce, US Retail Sales Jump 18% In May
Article By:
Adam Vettese
Read
Wednesday, June 17, 2020 5:16 AM EDT
Stock markets in the US, UK and Europe jumped yesterday and this morning on several pieces of news. First up, retail sales in the US mounted a comeback in May, jumping by 17.7% in their biggest monthly increase ever.
Royalty Pharma Merits Private Equity Drug Discount
Article By:
Lipper Alpha Insight
Read
Wednesday, June 17, 2020 4:42 AM EDT
Prescription drug pricing is a hot-button issue among U.S. voters, and a sweeping win by the Democrats could bring price controls – which would especially hurt indebted players like Royalty.
Cannabis Central: Check Out These 12 Pot Stocks With Major Momentum
Article By:
Lorimer Wilson
Read
Wednesday, June 17, 2020 4:09 AM EDT
Here are 12 pot stocks with major momentum. These stocks are outperforming the total cannabis stock universe of 298 stocks by 2.2% to 0.3%.
In this article: GWPH, CRBP, IIPR, GRWG, TSNDF, TCNNF, KERN, GNLN, XPHYF, CCHWF (NOW CBSTF), ABAHF, ROMJF
Market Briefing For Wednesday, June 17
Article By:
Gene Inger
Read
Wednesday, June 17, 2020 2:43 AM EDT
The repeated and projected rallies off the 200-Day Moving Average, would not have been blessed with success if not for favorable news on the COVID-19 front as well as a continually friendly Fed.
Market Briefing For Tuesday, June 16
Article By:
Gene Inger
Read
Tuesday, June 16, 2020 2:33 AM EDT
Business is booming - for certain sectors, and clearly has responded to those Government policies that have contributed to asset growth and stabilization for a fairly solid cross-section of Americans that work, did work, or normally work.
Cannabis Central: Sector Down 26% YTD But 9 NPSI Constituents Are Up As Much As 213%
Article By:
Lorimer Wilson
Read
Monday, June 15, 2020 4:14 PM EDT
YTD the 39 NPSI constituents are only down 4% compared to the cannabis sector as a whole (298 stocks) which is down 26%. This article identifies the extent to which 11 of them advanced (and 27 of them declined) over the past 5.5 months.
3 High Growth Cannabis Markets To Watch Going Into The Second Half Of 2020
Article By:
Technical420
Read
Monday, June 15, 2020 11:05 AM EDT
During the last year, US cannabis firms have been reporting impressive growth and this is a trend that we expect to continue for the foreseeable future.
Applications Of Genome Editing Technology In The Targeted Therapy Of Human Diseases Bolster The Genome Editing/Genome Engineering Market
Article By:
Steve Blade
Read
Monday, June 15, 2020 6:18 AM EDT
Using powerful, proven next-generation sequencing (NGS) and microarray solutions, researchers are now able to read and understand genetic variations at new depths. Some companies are very good at this.
Moderna - A Step Closer To Coronavirus Vaccine: ETFs To Gain
Article By:
Zacks Investment Research
Read
Sunday, June 14, 2020 3:44 PM EDT
The first company to start human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has informed that it is on schedule to initiate the final-stage clinical trial by July.
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Article By:
Benzinga
Read
Sunday, June 14, 2020 3:13 PM EDT
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
In this article: MRK, EVOK, RARE, EPZM Also: AZN, GILD, BMY, SNY, RPRX, CELG, PRQR, NBRV, CBIO, UROV, CNTG
Building Products Maker Azek Surges In Debut
Article By:
The Fly
Read
Sunday, June 14, 2020 2:18 PM EDT
After opening higher, building products maker Azek ended its first trading day up over 18%. The company raised about $765 million in the biggest initial public offering of the week.
In this article: RNA Also: BAC, GS, WFC, VXX, JEF, TREX, CS, LLY, COWN, SIVBQ, JPM, MS, EVR, RPRX, ADCT